This application claims priority to Taiwan Application Serial Number 110107796, filed Mar. 4, 2021, which is herein incorporated by reference.
The present disclosure relates to a perfusion cell culture device and a perfusion cell culture system. More particularly, the present disclosure relates to a perfusion cell culture device and a perfusion cell culture system with high-throughput.
Cell culturing, which can simply and directly reveal the activities and occurring messages in which of life, has played an important role in modern research field of biomedicine. Cell culturing refers to culture cells in vitro by simulating an appropriate environment in an artificial way. 2D cell culturing, a cell culturing method in early stage, is technically limited by a two dimensional surface, which not only results in an unstable cell growing environment, but is unable to maintain the original shape of cells. Therefore, 3D cell culturing has been developed. Although 3D cell culturing is able to keep cells maintaining their original shape and make cells further proliferate and differentiate, it is unable to simulate practical activities of human body since 3D cell culturing has a lack of circulation mechanism. Therefore, 3D cell culturing cannot effectively approach the real physiological environment, and the technique of perfusion cell culturing has been developed.
The conventional perfusion cell culture system is expensive and complicated to use. In addition, the conventional perfusion cell culture system requires lots of additional devices, such as air compressor, controller and gas cylinder, which make the overall system become bulky and hard to achieve the objective of high-throughput culturing. Therefore, it is important to develop a perfusion cell culture device with high-throughput which conduces to simplifying the system scale.
According to one aspect of the present disclosure, a perfusion cell culture device includes a driving module and a plurality of cell culture modules. The driving module includes a driving source connecting opening and a chamber. The chamber and the driving source connecting opening are connected. Each of the culture modules includes a fluid channel, a first elastic element, two flow direction controlling units and a cell culture zone. The fluid channel is disposed above the chamber, the first elastic element is disposed between the fluid channel and the chamber, the two flow direction controlling units are respectively disposed on two ends of the fluid channel and connected to the fluid channel selectively, and the cell culture zone is connected to the two flow direction controlling units.
According to another aspect of the present disclosure, a perfusion cell culture system includes a perfusion cell culture device of the aforementioned aspect and a driving source. The driving source is connected to the driving source connecting opening.
The present disclosure can be more fully understood by reading the following detailed description of the embodiment, with reference made to the accompanying drawings as follows:
Please refer to
The driving source connecting opening 210 can externally connect with a driving source so as to apply force to make the first elastic element 320 disposed between the fluid channel 310 and the chamber 220 operate, and further make the fluid in the fluid channel 310 such as culture medium flow due to the pressure change. Further, the two flow direction controlling units 330a, 330b can control the fluid to flow in a single direction to create a cell culturing environment with a circulation mechanism. Moreover, the cells, drugs and culture medium for cell culturing or drug screening can be placed or added in the cell culture zone 340. Besides, the driving module 200 can further include a through hole 230 connecting to the chamber 220, and is used for balancing the pressure in the chamber 220. The through hole 230 can be opened and closed when it is necessary or unnecessary, respectively. The structure and the operation detail of the perfusion cell culture device 100 will be further described in another aspect of the present disclosure, please refer to it.
Please refer to
The fluid channel 610 is disposed above the chamber 520, and the first elastic element 620 is disposed between the fluid channel 610 and the chamber 520. The two flow direction controlling units 630a, 630b are respectively disposed on two ends of the fluid channel 610, and are selectively connected to the fluid channel 610. The cell culture zone 640 is connected to the flow direction controlling unit 630a. The fluid storage tank 650 is connected to the cell culture zone 640, and is used for storing materials such as culture medium or drugs. The fluid outlet 660 is connected to the fluid storage tank 650. One end of the fluid inlet 670 is connected to the fluid outlet 660 and the other end of the fluid inlet 670 is connected to the flow direction controlling unit 630b. That is, the cell culture zone 640 and the flow direction controlling unit 630a are connected and the cell culture zone 640 is connected to the flow direction controlling unit 630b through the fluid storage tank 650, the fluid outlet 660 and the fluid inlet 670.
In the aspect of the present disclosure, the first elastic element 620 can be made of a polydimethylsiloxane film that a thickness thereof is in a range of 60 μm to 180 μm. Moreover, the fluid can be culture medium. The number of the cell culture modules 600 is two, but the present disclosure is not limited thereto. In other aspects of the present disclosure, the number of the cell culture modules 600 can be four, six, eight, ten or even further more.
Please refer to
Please refer to
The slit 632a of the second elastic element 632 is used for connecting the flowing space 631 and the fluid channel 610 selectively. In detail, when a positive pressure is applied to the flow direction controlling unit 630a, the second elastic element 632 in the flowing space 631 stretches therefore, which induces the flowing space 631 being connected to the fluid channel 610 through the slit 632a. On a contrary, when a negative pressure is applied to the flow direction controlling unit 630a, the second elastic element 632 in the flowing space 631 shrinks, and thus blocking the connection between flowing space 631 and the fluid channel 610. Therefore, the flow direction controlling unit 630a can make the fluid flow in a single direction, and to create a cell culturing environment with a circulation mechanism. In the aspect of the present disclosure, the number of the slit 632a is four, and four slits 632a are separated to each other in a same interval distance, but the present disclosure is not limited thereto. As long as the flowing space 631 and the fluid channel 610 can be connected.
In the aspect of the present disclosure, the second elastic element 632 can be made of a polydimethylsiloxane film that a thickness thereof is in a range of 60 μm to 180 μm. Moreover, the polymer dish plate 633 can be used for being attached by the second elastic element 632 during shrinking, to achieve a better sealing effect and reduce the possibility of the fluid backflowing. In the aspect of the present disclosure, the material of the polymer dish plate 633 can be polyethylene terephthalate or polydimethylsiloxane. In other aspects of the present disclosure, the amount of the polymer dish plate 633 can be two, and the materials of the two polymer dish plate 633 are polyethylene terephthalate film and polydimethylsiloxane, respectively, but the present disclosure is not limited thereto.
It is worth to mention that the perfusion cell culture device 400 can be made by microfabrication technology. In detail, laser cutting technology and structure design can be utilized to fabricate the perfusion cell culture device 400 by layer-by-layer stacking method. Materials of each layer of the perfusion cell culture device 400 can be polyethylene terephthalate or polydimethylsiloxane. Therefore, the absorption of the drugs what would like to be detected by the device can be prevent during the drug screening process, and further affect the screening result, that is, since the driving module 500 and the cell culture module 600 of the perfusion cell culture device 400 are both multilayer structure. Thus, the materials of the driving module 500 and the cell culture module 600 can be polyethylene terephthalate, polymethyl methacrylate or a combination thereof, and the materials of the first elastic element 620 and the second elastic element 632 can be further replaced to polydimethylsiloxane. Moreover, each layer of the perfusion cell culture device 400 can be assembled by a biocompatible glue. Therefore, the perfusion cell culture device 400 can be reuse after sterilization by ultra-visible light.
Please refer to
Please also refer to
It is worth to mention that as long as the driving source 810 can apply a force to the chamber 520 of the driving module 500 to wave the first elastic element 620 of the cell culture module 600, so that the arrangement of the auxiliary driving unit 820 is not essential. For example, in other aspects of the present disclosure, the driving source 810 can be a pump like a peristaltic pump, a syringe pump or a diaphragm pump, by pumping air to the chamber 520 of the driving module 500 to wave the first elastic element 620 so as to promoting the fluid in the fluid channel 610 flows.
Please refer to
Please refer to
Please refer to
In summary, the perfusion cell culture device of the present disclosure can simultaneously drive the fluid in each of the cell culture modules flows by using a single driving source. The perfusion cell culture device cooperates with the flow direction controlling units disposed on two ends of each of the fluid channel, which can form a cell culturing environment with circulation mechanism with each of the cell culture zone, and multiple sets of the perfusion cell culturing process can be carried out simultaneously. Moreover, each unit of the perfusion cell culture device, such as the fluid channel and the fluid storage tank, can have different shape or size to each other and can also be adjusted on demand, which achieves the goal of culturing cells under different conditions in the same time. Therefore, the perfusion cell culture device of the present disclosure can achieve not only the objective of high-throughput and simplifying the system scale, but is also conductive to long term cell culturing or drug screening, which is helpful to the research of the diseases such as cancer.
Besides, the perfusion cell culture system of the present disclosure can carry out multiple sets of the perfusion cell culturing process by one single driving source, which is simple to operate. In contrast to the conventional perfusion cell culture system, the perfusion cell culture system of the present disclosure can further reduce the cost and the needed space of the apparatus.
Although the present disclosure has been described in considerable detail with reference to certain embodiments thereof, other embodiments are possible. Therefore, the spirit and scope of the appended claims should not be limited to the description of the embodiments contained herein.
It will be apparent to those skilled in the art that various modifications and variations can be made to the structure of the present disclosure without departing from the scope or spirit of the disclosure. In view of the foregoing, it is intended that the present disclosure cover modifications and variations of this disclosure provided they fall within the scope of the following claims.
Number | Date | Country | Kind |
---|---|---|---|
110107796 | Mar 2021 | TW | national |
Number | Name | Date | Kind |
---|---|---|---|
10160944 | Coppeta | Dec 2018 | B2 |
20190093059 | Sugiura | Mar 2019 | A1 |
Number | Date | Country |
---|---|---|
1737157 | Feb 2006 | CN |
201139667 | Nov 2011 | TW |
201204831 | Feb 2012 | TW |
WO-2017096285 | Jun 2017 | WO |
Entry |
---|
Wei-Han Lai, “Development of Hydraulically-Driven Microperfusion Cell Culture Platform for High-Throughput Drug Screening”, Graduation Thesis Oral Defense for master's degree of Department of Chemical Engineering, National Tsing Hua University, dated on Jun. 24, 2020, oral presentation, Taiwan, R.O.C. |
Number | Date | Country | |
---|---|---|---|
20220282196 A1 | Sep 2022 | US |